🔎 Trials Near Me

Home › Cancro alla prostata › Utah

Studi clinici su Cancro alla prostata nello stato di Utah

24 studi su Cancro alla prostata cercano partecipanti presso sedi nello stato di Utah.

Città nello stato di Utah

Testo ufficiale dello studio (inglese)

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

  • Intermountain Medical Center, Murray
  • McKay-Dee Hospital Center, Ogden
  • LDS Hospital, Salt Lake City
  • e altri 2
In reclutamentoFase 3
Età 18 e oltre · Uomini · Aggiornato il 2 ott 2026 · NCT06931340

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

  • University of Utah - Huntsman Cancer Institute, Salt Lake City
  • START Mountain Region, West Valley City
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT06465069

Study of AR Suppression With Carotuximab in Metastatic, Castration-Resistant Prostate Canc

  • Huntsman Cancer Institute and Hospital, Salt Lake City
In reclutamentoFase 2
Età 18 e oltre · Uomini · Aggiornato il 30 set 2026 · NCT05534646

A Study of JNJ-98768111 in Participants With Advanced Prostate Cancer

  • START Mountain Region, West Valley City
In reclutamentoFase 1
Età 18 e oltre · Uomini · Aggiornato il 25 set 2026 · NCT07746713

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

  • Utah Intermountain Medical Center, Murray
In reclutamentoFase 2/3
Età da 18 a 100 · Uomini · Aggiornato il 22 set 2026 · NCT06780670

First-Time-in-Human Study of GSK5471713 in Adults With mCRPC

  • GSK Investigational Site, West Valley City
In reclutamentoFase 1/2
Età 18 e oltre · Uomini · Aggiornato il 16 set 2026 · NCT07332455

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

  • Intermountain Health, Murray
In reclutamentoFase 3
Età 18 e oltre · Uomini · Aggiornato il 11 set 2026 · NCT06056830

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

  • American Fork Hospital / Huntsman Intermountain Cancer Center, American Fork
  • Sandra L Maxwell Cancer Center, Cedar City
  • Farmington Health Center, Farmington
  • e altri 9
In reclutamentoFase 3
Età 18 e oltre · Uomini · Aggiornato il 10 set 2026 · NCT05946213

A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)

  • Summit Urology, Murray
In reclutamentoFase 3
Età 18 e oltre · Uomini · Aggiornato il 3 set 2026 · NCT07723248

AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)

  • Research Site, Salt Lake City
In reclutamentoFase 3
Età 18 e oltre · Uomini · Aggiornato il 26 ago 2026 · NCT07611110

Study of Oral MRT-2359 With Apalutamide in Prostate Cancer

  • START Mountain Region, West Valley City
In reclutamentoFase 2
Età 18 e oltre · Uomini · Aggiornato il 24 ago 2026 · NCT07745361

Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

  • Intermountain Medical Center, Murray
In reclutamentoFase 1
Età 18 e oltre · Uomini · Aggiornato il 21 ago 2026 · NCT04221542

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

  • Huntsman Cancer Institute/University of Utah, Salt Lake City
In reclutamentoFase 3
Età 18 e oltre · Uomini · Aggiornato il 14 lug 2026 · NCT06592924

Study of ORIC-944 in Patients With Metastatic Prostate Cancer

  • Huntsman Cancer Institute, University of Utah, Salt Lake City
In reclutamentoFase 1
Età 18 e oltre · Uomini · Aggiornato il 9 lug 2026 · NCT05413421

Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors

  • START Mountain Region, West Valley City
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 10 giu 2026 · NCT07517198

Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer

  • Huntsman Cancer Institute/University of Utah, Salt Lake City
In reclutamentoFase 2
Età 18 e oltre · Uomini · Aggiornato il 5 giu 2026 · NCT05168618

Creatine Supplementation and Resistance Training to Preserve Muscle Mass and Attenuate Cancer Progression

  • Huntsman Cancer Institute, Salt Lake City
In reclutamentoFase 3
Età 18 e oltre · Uomini · Aggiornato il 3 giu 2026 · NCT06112990

Multimodal Telerehabilitation of Rural Patients With Advanced Prostate Cancer

  • Huntsman Cancer Institute at University of Utah, Salt Lake City
In reclutamento
Età 18 e oltre · Uomini · Aggiornato il 13 apr 2026 · NCT07093177

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

  • START Center for Cancer Care - Mountain Region, Salt Lake City
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 27 mar 2026 · NCT06395519

Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors

  • START, Mountain Region, West Valley City
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 17 feb 2026 · NCT07145255

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Salt Lake City
In reclutamentoStudio osservazionale
Tutte le età · Tutti i sessi · Aggiornato il 28 ott 2025 · NCT03452774

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

  • University of Utah Sugarhouse Health Center, Salt Lake City
  • Huntsman Cancer Institute/University of Utah, Salt Lake City
  • George E Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
In reclutamentoFase 3
Età 18 e oltre · Uomini · Aggiornato il 11 set 2025 · NCT03678025

Impact of Multimodal Telerehabilitation in Rural Patients With Metastatic Prostate Cancer

  • University of Utah Huntsman Cancer Institute, Salt Lake City
In reclutamento
Età 21 e oltre · Uomini · Aggiornato il 1 ago 2025 · NCT07032584

Fonte: ClinicalTrials.gov, dati recuperati il 4 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.